Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind ACYW135 meningococcal conjugate vaccine trial in 6–23‑month-old infants/young children
CTR20201731Phase 3Completed
- Sponsor
- Walvax Biotechnology Co., Ltd.
- Start
- Sep 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of A, C, Y, W135 meningococcal polysaccharide vaccine in meningococcal meningitis, sponsored by Walvax Biotechnology Co., Ltd.. Started Sep 2020; status: completed.
02
Drugs
A, C, Y, W135 meningococcal polysaccharide vaccine
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on CTR20201731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201731.